BON - CIK 0001816815
Bon Natural Life Ltd trades as BON. In its fiscal 2025 annual report the company posted revenue of $18.67M, down 21.7% from the prior year and net income of -$1.99M. This page tracks Bon Natural Life Ltd through 151 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 6 fiscal years Bon Natural Life Ltd's revenue grew from $16.40M to $18.67M, a compound annual growth rate of 2.2%. Net profit margin compressed from 15.7% to -10.7% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| New insider ownership | 3 | 2026-05-15 |
| New insider ownership | 3 | 2026-04-23 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
The largest companies sharing Bon Natural Life Ltd's SEC industry classification (medicinal chemicals & botanical products).
Bon Natural Life Ltd reported revenue of $18.67M for fiscal year 2025, a decrease of 21.7% year over year.
In its latest fiscal year Bon Natural Life Ltd reported a net loss of $1.99M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.